BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29439188)

  • 41. CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
    Fridrik MA; Hausmaninger H; Linkesch W; Stöger M; Sill H; Neubauer M; Seewann HL; Klocker J; Haidinger R; Schiller L; Pont J; Raudaschl G; Falk M; Radaszkiewicz T
    J Clin Oncol; 1996 Jan; 14(1):227-32. PubMed ID: 8558202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
    Unterhalt M; Herrmann R; Tiemann M; Parwaresch R; Stein H; Trümper L; Nahler M; Reuss-Borst M; Tirier C; Neubauer A; Freund M; Kreuser ED; Dietzfelbinger H; Bodenstein H; Engert A; Stauder R; Eimermacher H; Landys K; Hiddemann W
    Leukemia; 1996 May; 10(5):836-43. PubMed ID: 8656680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-Hodgkin's lymphoma among patients infected with human immunodeficiency virus: the experience of a single center in Brazil.
    Tanaka PY; Pracchia LF; Calore EE
    Int J Hematol; 2006 Nov; 84(4):337-42. PubMed ID: 17118760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastrointestinal lymphomas in patients with AIDS.
    Powitz F; Bogner JR; Sandor P; Zietz C; Goebel FD; Zoller WG
    Z Gastroenterol; 1997 Mar; 35(3):179-85. PubMed ID: 9106981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
    Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
    J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modern management of non-Hodgkin lymphoma in HIV-infected patients.
    Mounier N; Spina M; Gisselbrecht C
    Br J Haematol; 2007 Mar; 136(5):685-98. PubMed ID: 17229246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [HIV-associated malignant lymphomas].
    Egli F; Baumann R; Bernasconi E; Opravil M
    Schweiz Med Wochenschr; 1992 Apr; 122(14):495-502. PubMed ID: 1348590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
    Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
    Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.
    Navarro JT; Ribera JM; Oriol A; Vaquero M; Romeu J; Batlle M; Flores A; Millá F; Feliu E
    Br J Haematol; 2001 Mar; 112(4):909-15. PubMed ID: 11298585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymphoma in HIV-2-infected patients in combination antiretroviral therapy era.
    Ronchetti AM; Matheron S; Galicier L; Damond F; Mahjoub N; Chaghil N; Meignin V; Mechaï F; Simon F; Oksenhendler E; Gérard L
    AIDS; 2021 Nov; 35(14):2299-2309. PubMed ID: 34231524
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
    Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT;
    Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Lichtman SM; Brody J; Kaplan MH; Susin M; Koduru P; Goh JC
    Leuk Lymphoma; 1993 Mar; 9(4-5):393-8. PubMed ID: 7688628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P; Guilhot F; Bordesoule D; Renou P; Benz-Lemoine E; Fouillard L; Drouet M; Tanzer J; Lamagnere JP
    Haematologica; 1991; 76(6):479-84. PubMed ID: 1726492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral combination chemotherapy in the management of AIDS-related lymphoproliferative malignancies.
    Remick SC; Sedransk N; Haase R; Craffey M; Subramanian N; Dowlati A; Nazeer T; Ramnes C; Blanchard C; Mastrianni D; Balducci L; Horton J; Ruckdeschel JC
    Drugs; 1999; 58 Suppl 3():99-107. PubMed ID: 10711848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
    Ratner L; Lee J; Tang S; Redden D; Hamzeh F; Herndier B; Scadden D; Kaplan L; Ambinder R; Levine A; Harrington W; Grochow L; Flexner C; Tan B; Straus D;
    J Clin Oncol; 2001 Apr; 19(8):2171-8. PubMed ID: 11304769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in the management of HIV-related non-Hodgkin lymphoma.
    Behler CM; Kaplan LD
    Curr Opin Oncol; 2006 Sep; 18(5):437-43. PubMed ID: 16894290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.